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The venom from the brown recluse spider, Loxosceles 
reclusa, contains one or more factors which produce skin 
necrosis. A dermonecrotic factor with sphingomyelinase 
D activity was purified from the spider's venom sacs 
which produced skin necrosis when injected intrader-
mally in rabbits. Adsorption of the dermonecrotic activ-
ity occurred following incubation with isolated mem-
branes from different cell types or different species in a 
dose-responsive fashion. Since injection of the complex 
in rabbits produced skin necrosis, a specific antibody 
that inhibits the dermonecrotic activity and sphingo-
myelinase activity was used to identify the venom frac-
tion on the plasma membrane of erythrocytes with elec-
tron microscopy. Initiation of cutaneous inflammatory 
reaction may result from high-affinity interaction of a 
venom component in the brown recluse spider venom 
and cell membranes. 
The brown recluse (BR) spider, Loxosceles reclusa, is indige-
nous to the central and southeastern United States, where its 
bite is notorious for producing skin necrosis. The BR bite site 
is characterized by a polymorphonuclear (PMN) leukocyte 
infiltration, platelet thrombi, and vascular thrombosis [1], in 
some cases resembling pyoderma gangrenosum or other neutro-
philic dermatoses. In humans, this intense, cutaneous inflam-
mation is resistant to treatment with systemic steroids, heparin, 
or early surgical excision [2,3]. 
Efforts to develop a more effective therapy for BR spider 
bites have been complicated by differences in venom prepara-
tions [4- 6) used to study the mechanism(s) of action. As an 
example, BR venom fractions collected by electrostimulation 
[ 4) may contain pro teases and other factors of salivary gland 
or stomach origin which represent contaminants presumably 
unrelated to the dermonecrotic activity. However, "purified" 
BR venom contains numerous proteins and biologic activities. 
Even when venom was obtained by microdissection of venom 
sacs and purified by column chromatography [5,6) or gel elec-
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trophoresis, there was alkaline phosphatase [5,6], 5' -ribonu-
cleotide phosphohydrolase [5], hyaluronidase [5,6], esterase 
[5,6], and protease [5) activity recovered from the venom. 
Forrester et al [7] first identified a sphingomyelinase D-like 
activity from crude BR venom and have suggested that this 
enzyme may be responsible for the hemolysis produced by BR 
venom. 
Although many factors have been implicated in the formation 
of BR lesions, the precise mechanism of initiation remains 
obscure. Using a crude venom preparation, Futrell et a! [8) 
demonstrated immunocytochemically venom components on 
the plasma surface of the red blood cell (RBC) membrane. 
Similarly, Schenone and Suarez [9) induced dermonecrotic 
lesions by injection of erythrocytes previously incubated with 
Loxosceles laeta venom. These observations imply that factors 
present in the venom may have great affinity for cell mem-
branes acting in concert with leukocytes [10], complement 
[11], C-reactive protein [12], or other unknown factors to 
produce dermonecrosis. In these experiments, we have investi-
gated the general nature of venom's affinity for all types of cell 
membranes, using a well-characterized venom fraction which 
contains sphingomyelinase D activity. Moreover, we have lo-
calized the adsorption of the venom fraction to the plasma 
surface of the RBC membrane with an antibody that abolishes 
the biologic activity and the sphingomyelinase activity and 
binds immunocytochemically to the venom fraction . 
MATERIALS AND METHODS 
All chemicals, unless otherwise specified, were of reagent grade from 
common commercial sources and used without further purification. 
Limulus amebocyte lysate (Pyrostat reagent kit) was from Worthington 
(Freehold, New Jersey), while protease detection and protein assay kits 
were from BioRad (Richmond, California). The ["C]sphingomyelin 
was obtained from New England Nuclear (Boston, Massachusetts) . For 
electron microscopy (EM) studies, the protein A-colloidal gold was 
purchased from Polysciences (Warrington, Pennsylvania), embedding 
plastic (Medcast plastic) from Ted Pella (Tuscin, California), and 
cationic ferritin from Miles (Napierville, Illinois). The electroblot 
apparatus was from E-C Apparatus Corp. (St. Petersburg, Florida). 
Nitr?cellulose paper (Millipore, type HA pore size 0.45 ,.,m) , normal 
rabb1t serum, normal calf serum , ami do black, and protein A sepharose 
CL-4B beads were from Sigma (St. Louis, Missouri) . Miles Laboratories 
was the source of peroxidase-antiperoxidase (PAP), and 3,3' -diamino-
benzidine tetra-hydroch loride came from Aldrich Chemical (Milwau-
kee, Wisconsin). Dragendorff 's reagent and chromatography sheets 
were from Whatman (Ann Arbor, Michigan). Silica gel plates (250 ,., ml 
were from Analtech (Newark, Delaware) and cellulose TLC sheets (160 
,.,m) from Eastman (Rochester, New York). 
Animals were obtained from the following sources: New Zealand 
white rabbits- Hi lltop Rabbit Ranch, Columbia, T ennessee; Hartley 
guinea pigs-Williams Kentucky Caves, Fern Creek, Kentucky; Spra· 
gue-Dawley rats and CF-1 outbred albino mice- Harlan Industries, 
Indianapolis, Indiana; and Suffolk sheep- Surgical Research Labora· 
tory, Vanderbilt University Medical Center, Nashville, Tennessee. 
Collection of Spider Venom Sacs 
The spiders for this study were collected during warm summer nights. 
They were found in old barns, abandoned houses, or unused buildings 
and caught alive in medicine cups. After a 4-day period, the spiders 
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were frozen and stored at -20'C. The chelicerae (mandibles) and 
venom sacs were dissected from frozen spiders as previously described 
[3) . 
Preparation of the Venom Fraction 
Venom fractions were purified essentially using the method reported 
by Beckwith, Babcock, and Geren [13], as previously described [14]. 
Briefly, microdissected venom sacs were divided into lots of 100 and 
weighed and suspended in 2 rnl of sodium citrate buffer (0.02 M, pH 4) . 
The sacs were crushed lightly with a glass rod for 5 min, and the crude 
pellet was removed by centrifugation (15 min, 8000 g, 4 'C). The 
supernatant (8 1) was decanted, and the crude pellet was resuspended 
in buffer. The pellet was crushed again lightly for 5 min, centrifuged 
(15 min, 8000 g, 4 'C), and the second supernatant (82) was removed. 
The supernatants were pooled (8 1 + 8 2 ) , frozen in liquid nitrogen for 5 
min, and thawed to room temperature. When the combined superna· 
tants were thawed, a precipitate formed that was removed by centnf-
ugation (10 min, 10,000 g), and supernatant (83) was recovered. 
Polyacrylamide Gel Electrophoresis of Venom Fractions 
Venom samples were solubilized, boiled, and prepared for separation 
by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis 
(7.5% acrylamide), as previously described [15]. Gels were fixed and 
stained with Coornassie blue or periodic Acid-Schiff (15]. 
Assays for Enzymatic Activity of Venom 
Proteolytic activity of the venom fraction was tested by a BioRad 
protease detection ~it. An aliquot (1 11gl of S,. was in cub~ ted for _12 h 
at 4 ' C in wells cut 111 a 1% agar gel plate contammg bovme casem 111 
Tris-buffered isotonic saline, pH 7.4. Serum-containing plasminogen 
activated by urokinase was used as a positive control reaction. Proteo-
lytic activity of the positive control was directly proportional to the 
area of caseinolysis [16]. 
Serine esterase activity of 83 was tested [17] by inhibition of biologic 
activity with phenyl methyl sulfonyl fluoride (PMSF) . The 83 fraction 
(100 JJ.g) was suspended in either 2.5% methanol or 2.5% methanol-
0.04 M PMSF and then reacted for 1 h at 37' C. The mixture was 
dialyzed in distilled water for 24 h at 4 ' C, and 20-l'g aliquots were 
injected into a rabbit. Solutions of 2.5% methanol, 2.5% methanol-
0.04 M PMSF, and 83 were injected as controls. 
The presence of sphingomyelinase in the 83 fraction was assayed 
using a modification of the procedure described by Hysmith and Fran-
son [18]. An aliquot of [14C]sphingomyelin was diluted with unlabeled 
sphingomyelin in 1.5% Triton X-100 to obtain a stock solution of 10 
nrnol/ pi and 2000 cpm/pl. The suspension was heated (<60'C) and 
vortexed to solubilize the sphingomyelin. Following a preincubation (5 
min, 37'C) of 0.5 11g of S,. fraction in 20 mM Hepes, pH 7.0, and 8 mM 
CaCb, the sphingomyelin suspension (10 111) was added to make a final 
reaction volume of 0.5 ml and the mixture incubated at 37' C for 60 
min. The reaction was terminated by the addition of 1.5 ml of 
CHCL3:MeOH (2:1) , 0.5 ml of 1 M KCl, and 0.5 ml CHCb. The phases 
were separated by centrifugation (2000 g, 5 min) and 0.5-ml aliquots of 
the upper phase counted in the gamma spectrometer. 
Aliquots of the aqueous layer were also concentrated and chroma-
tographed in the following systems as described by Forrester et at 
[7]: (1) Cellulose thin-layer chromatography (TLC), n-butanol: 
ethanol:acetic acid:water (8:2:1:3); (2) Silica gel TLC, methanol :water:7 
M NH40H (6:3:1); and (3) paper chromatography, n -butanol:acetic 
acid:water (5:2:3). Detection of spots was made on TLC plates by 
Dragendorffs reagent and [14C) radioactive label. 
Assay for Biologic A ctivity 
Dermonecrotic activity of BR venom sac fractions was tested by 
injection of 5- 25 11g of the 83 fraction in 250 11l of isotonic saline 
intradermally into the shaved backs of female New Zealand Wh1te 
rabbits, as previously described [3]. Similar injections of 83 fract1_on 
bound to cell membranes were made to test the dermonecrotic act1v1ty 
of S 3 fraction in a dose-dependent fashion . The diameter of lesions was 
measured at 24 h and photographed with a single lens reflex camera 
(Qlympus-Orn-1) with a macro lens (Vivitar, 90 mm). There were 5 
determinations for each data point and the mean pomt plotted. The 
Student t-test was used for statistical analysis, and the standard error 
was plotted with the mean in the bar graphs (see Fig 5). Each series of 
experiments required at least 3 animals. . 
Sites of venom injection or sham injections were removed surg1cally, 
fixed, processed, and stained to confirm in vivo effects of venom in 
different species. Dermonecrotic active fractions were tested for endo-
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toxin activity by the Pyrostat assay kit which spectrophotometrically 
measures the presence of clottable protein in Limulus amebocyte lysate 
exposed to endotoxin. Escher£chia coli was used as a standard for the 
assay. 
Preparation. and Characteristic of Antibody 
Preparation. of antibody: A specific antibody against the BR venom 
dermonecrotic fraction was raised in New Zealand White rabbits by an 
initial i.m. injection of 10 11g of 83 followed by repeated i.rn. injections 
of 83 3 times a week for 3 months [3]. Immune rabbit serum was 
initially collected weekly following immunization, and intermittently 
thereafter as needed for antibody studies. Immunoreactivity of rabbit 
serum was tested with agarose immunodiffusion plates using S3 fraction 
(4.6 mg/ rnl) and undiluted rabbit serum. The antibody's biologic activ-
ity was tested in rabbits by incubation with the 83 in vitro or by direct 
injection of antibody into skin lesions. 
Technique of electroblot transfer of venom for antibody identification: 
Partially purified venom fraction was first;. separated on a 5-10% 
gradient SDS polyacrylamide gel run overnight at 10 rnA and at 40 rnA 
the following morning until the tracking dye reached 10 em on a 15-
cm slab gel. The gel was placed in the electroblot apparatus adjacent 
to nitrocellulose paper in buffer, as described by Towbin et at [19], and 
transferred for 11/ 2 hat 0.2 mA. Nitrocellulose paper was then incubated 
with immune rabbit serum at a dilution of 1:10 or 1:100 and immuno-
reactive proteins identified using PAP and 3,3'-diaminobenzidine, as 
described by Glass et al [20]. Normal rabbit serum was used as the 
control. Duplicate nitrocellulose sheets were stained for protein iden-
tification with 0.1 % arnido black in 45% rnethanol:lO% acetic acid 
followed by 90% methanol:2% acetic acid to destain the nitrocellulose 
paper. 
Isolation. of IgG antibody: Protein A sepharose CL-4B (500 mg) was 
swollen in 0.1 M NaH2PO. buffer, pH 4, at 4 ' C and the slurry packed 
into a 53/• inch Pasteur pipet plugged with a glass wool filter. The 
column was equilibrated with buffer, after which 7 rnl of immune rabbit 
serum was placed on the column. The eluate was collected and the 
process repeated to insure maximum yield of lgG. The column was 
washed with 2 column volumes of buffer followed by elution of lgG 
fraction with 0.1 M glycine, pH 2.6. The IgG fraction eluted by glycine 
buffer was dialyzed overnight in phosphate-buffered saline (PBS), pH 
7.4, at 4' C and stored at -20' C. 
Preparation of Cell Membranes and Venom Membrane Complexes 
Preparation. of cell membranes: Human blood products were obtained 
either as fresh samples from human volunteers or as outdated blood 
from Vanderbilt University Medical Center Blood Bank and the Nash-
ville branch of the American Red Cross. 
The RBCs from sheep, humans, rats, and rabbits were collected in 
tubes containing a 14% (v/v) acid-citrate dextrose concentration. The 
RBCs were washed in isotonic saline and centrifuged in a Sorvall RCB -
3 for 10 min at 1500 g. The RBCs were lysed with hypotonic Tris buffer 
(0.01 M, pH 7.4), washed, centrifuged for 10 min at 27,000 g, and 
prepared as "white membrane ghosts" [ 15]. After the membrane protein 
concentration was determined (4-8 mg/ml), membranes were resus-
pended in Tris buffer at a final concentration of 1 11gj l't. 
A human epidermoid cancer cell line (A-431) was grown in tissue 
culture, and membranes (10 mg/ ml) were prepared after the method of 
Thorn et at [21] . 
Rat hepatocyte membranes (2 mg/ml) were prepared after the 
method of Aronson and Touster [22]. 
Preparation of the S3-cell membrane complex: 8 3 (5-25 !'g) was 
suspended in 250 11l of isotonic saline and incubated for 1 h at 37' C 
with the various cell membrane preparations (500 11g membrane pro-
tein). The 83- membrane complexes were washed repeatedly with iso-
tonic saline and centrifuged 3 times for 10 min at 5000 g before 
resuspension in 250 1!1 of isotonic saline and injection intradermally 
into rabbits. 
Enzyme digestion. of cell membranes: The RBC membranes were 
treated with trypsin or neuraminidase, as previously described [15]. 
Sheep RBC membranes (500 l'g) were suspended in 0.01 M Tris buffer, 
pH 7.4, and incubated for 10 min at 37'C with neuraminidase (0.1 mg/ 
ml) or trypsin TPCK (1.0 mg/ml). After enzyme-treated membranes 
were washed and centrifuged (5 min, 7000 g) to remove proteases, they 
were incubated for 1 h at 37'C with 8:1 fraction (5 11g) and injected into 
rabbits. 
Localizat£on of venom S3 fraction to the RBC rn.embranes: Human 
RBC membranes (500 l'g) were suspended in PBS and incubated with 
5 11g/ ml of S3 for 30 min at 37 ' C. Membranes were washed in PBS and 
272 REES ET AL 
incubated wit h immune rabbit sera for 1 h at 37"C, while control 
incubations were made with nonimmune rabbit sera. Aliquots of S3 
membrane complexes were extensively washed in PBS and incubated 
for l h with cationic ferritin suspended in 0.2 M phosphate buffer. All 
membranes were rinsed in PBS and incubated in protein A- colloidal 
gold for 1 h at 37"C [231. The complexes were rinsed in PBS and fixed 
in 2% gluta raldehyde in 0. 2 M phosphate butTer f or 18 h. Samples were 
rinsed in sucrose-phosphate buffer (0.3 M, pH 7.2) and dehydrated in 
a graded series of ethanols, processed through propylene oxide, and 
embedded in Medcast plastic. Thin sections were cut on an LKB 
ul t ramicrotome and noa ted onto copper grids. Sections were stained 
with uranyl acetate followed by lead citrate and photographed on an 
Hi tachi 600L t ransmission electron microscope. 
RESULTS 
Isolation and Characterization of the Dermonecrotic Activity 
Venom sacs of 800 BR spiders were dissected for use in this 
study. The 8,3 fraction contained an average of 79 J.Lg protein 
per spider (62- 125 J.Lg) , and the total protein yield of 8 3 from 
the 800 spiders was 60.08 mg. Dermonecrotic activity of the Sa 
fraction was nondialyzable (<10,000 M ,), heat labile (3 min, 
100•C) , and contained less than 0.4% endotoxin. The dialyzed 
S,. fraction was examined by SDS polyacrylamide electropho-
resis (Fig 1) . Coomassie-stained gels showed a major band of 
M, = 34,000 with a minor band at a higher molecular weight. 
No bands in the gel were stained by the periodic acid-Schiff 
method. Using a protease detection kit, S,. fraction demonstra-
ted no hydrolysis of casein, while the absence of esterase 
activity was confirmed by failure of PMSF to inhibit the 
venom 's dermonecrotic activity. The Sa fraction hydrolyzed 
[' 4C]sphingomyelin , and the radiolabeled product of the reac-
t ion was recovered in the aqueous phase of the reaction mixture. 
Detection of TLC spots by Dragendorfrs reagent and radioac-
tive label revealed a product with an Rr value equal to the 
choline standard , indicating a sphingomyelinase D cleavage. 
Although there was species variation in the concentration of 
S,. fraction required to produce a skin lesion, injection of S3 
fract ion into rabbits, guinea pigs, sheep, rats, and mice consist-
ently produced dermonecrosis. Lesion size was roughly propor-
t ional to t he concentration of Sa injected (see Fig 4). In rabbit 
m.w. 
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FI G l. SDS polyacrylamide electrophoretic separation of crude BR 
venom and dia lyzed S3 fraction. Crude BR venom and S3 were prepared 
from venom sacs, solubilized, separated by SDS gel electrophoresis, as 
described in the text. A, Crude BR venom. B, Partially purified S3. 
m.w. = Position of molecular weight markers; T.D. = position of 
t rac king eye. Molecula r weight markers in kilodaltons. 
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FIG 2. Dermonecrosis induced by S3 fraction (10 11g) of BR venom 
at 5 days. A, The 8:1 fraction was prepared as described in the text, and 
10 11g was injected intradermally into a rabbit's dorsal skin. The 
intradermal injection site was photographed at 24 h. B, Prior to 
injection of S3, the preselected intradermal injection was pretreated 
with antibody (6.7 mg) intradermally at the lesion site. 
TABLE I. Effect of antiserum on biologic activity of BR uenom 
BR venom Preimmune Antibody Buffer Lesion size 
(5 1Jg) serum (200 IJI) (200 IJI} ±SD (200 IJI) (em) 
+ 0.83 ± 0.29 
s3 + 1.75 ± 1.1 
+ 0 
+ 1±0 
Crude + 2 ± 0.7 
+ 0 
Crude venom or S3 fraction was preincubated (37"C, 1 h) with 
preimmune sera, antisera, or buffer and injected into rabbit. Lesions 
(n = 3) were measured at 24 h. 
skin, the typical lesion became erythematous, edematous, and 
warm by 12 h following injection. A characteristic papule 
formed at the injection site which was dusky purple, and the 
lesion spread in an irregular fashion from the spine to the 
abdomen of the animal (Fig 2A) . Histologic examination of 
dermonecrotic skin lesions from the rabbit demonstrated vas-
cular thrombosis, platelet thrombi, and intense PMN leukocyte 
infiltration throughout the dermis and subcutaneous tissue. 
Characterization of the Antibody Against S3 
The immune rabbit sera produced immunoprecipitation lines 
on immunodiffusion plates when exposed to the Sa fraction . 
Specificity of immunoreactive antibody was tested using elec-
troblot transfer of SDS gel purified venom fraction to nitrocel-
lulose paper. When a crude venom preparation (S1 + S2 ) was 
used to identify trace antibodies directed at other venom pro-
teins, a single M, = 34,000 protein band stained with nitrocel -
lulose paper. In contrast, nonimmune sera did stain nonspecif-
ically some high-molecular-weight proteins, but did not stain 
the M, = 34,000 band. 
Using this immunoreactive rabbit sera, we sought to char-
acterize the biologic activity of antibody against Sa fraction . 
When rabbit injection sites for S3 or crude venom were pre-
treated with immune antisera, the antibody abolished the der-
monecrotic activity or 83 and crude venom in vivo (Fig 2B ) 
(Table I). Moreover, incubation of venom with antibody abol-
ished sphingomyelinase activity as well. The protective effect 
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of immune rabbit serum was eliminated by preincubating it 2.5 
with protein A sepharose beads. Since this indicated t hat 
protective activity resided in the lgG fraction, immune antisera 
was purified using a protein A sepharose column with a yield 
of 14.4 mg of IgG obtained fro m 7 ml of sera. When biologic 
activity of the column-purified lgG fraction was compared with 
crude immune rabbit serum on a mg protein basis, purified IgG 
was 100 times more potent as an inhibitor of dermonecrosis 
t han crude antisera. The IgG antibody (500 J.Lg) reduced sphin-
gomyelinase D (5 1-1g) activity to 5.1% of control. 
Interaction of Venom and Cell Membranes 
Using our partially purified venom fraction, we sought to 
identify the initiating mechanism responsible for tissue injury. 
Since 8 3 produced an intense, highly localized inflammatory 
response, we considered the possibility that s3 does not diffuse 
from the injection site, but is adsorbed to cell membranes in 
situ . When 8 3 fraction was incubated with human, rat, rabbit, 
or s heep RBC membranes, injection of washed SR-membrane 
complexes produced skin necrosis in rabbits. The dermone-
crotic effect of 83 adsorbed to membranes was dose-dependent 
since larger concentrations of s3 incubated wit h the same 
amoun t of RBC membranes from all species produced propor-
tionately larger rabbit skin lesions (Fig 3). The high-affini ty 
interaction of s3 fraction to cell membranes was not limited to 
RBC membranes, but was present in all membrane systems 
tested. Complexes of S:J with human epithelial cell membranes 
or with rat hepatocyte membranes which were washed exten-
sively also produced dermonecrosis when injected into rabbit 
skin (Fig 4) . Rat hepatocytes and sheep RBC membranes had 
greater dermonecrotic activity at any given membrane concen -
tration, although all membranes bound sufficient venom to 
produce significant cutaneous lesions in rabbits . 
Since pretreatment of RBC membranes wit h proteolytic en-
zymes may modify charge interactions [15], sheep and human 
RBC membranes were t reated wit h trypsin and neuraminidase 
before incubation with S:~ fraction. There was no reduction 
noted in the dermonecrotic effect in RBC membranes when 
treated with neuraminidase or trypsin. 
Because preincubation of S:~ fraction with the serum ant ibody 
in vitro or local injection of ant ibody at t he injection site in 
vivo abolished dermonecrotic activity (Fig 28), we sought to 
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F IG 3. Adsorption of S3 fractio n to RBC membranes. Increasing 
concentrations of S, (5- 25 J.l g) were incubated wit h RBC membra nes 
prepa r e d as described in t he text. T he SrRBC membrane complexes 
were washed a nd centrifuged; aliquots were injected in traderma lly in to 
the rabbit. Lesion sizes were measured at 24 h. 
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FIG 4. Adsorption of Sa fraction to sheep RBC, epithe lia l cell, and 
hepa~ocyte membranes followed by washing to eliminate free S3 • In-
creasmg concentratiOns of S3 (5-25 J.lg) a lone or S3 incubated with cell 
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FIG 5. Lesion size in s,.- RBC membrane complexes treated with 
hyperimmune sera (Ab) or nonimmune sera. T here is a substa nt ia l 
reduction in lesion size when ei ther S,-RB C membranes or s ., a lone is 
incubated with hyperimmune sera before injection into the ra.bbit. 
determine whether Sa fract ion was accessible to antibody once 
adsorbed to the membrane. When immune rabbit antisera was 
incubated with S:~-RBC membrane complexes and injected into 
the rabbit, skin necrosis did not occur. Incubation with control 
sera did not abolish dermonecrotic activity (Fig 5). 
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Identification of Membrane Binding by Electron Microscopy 
To determine whether the venom produced dermonecrosis 
because it physically interacted with cell membranes, we used 
immunocytochemical techniques and EM to localize t he venom 
molecules. Using a protein A-gold complex as an electron-
dense marker, the sites of s~-membrane interactions were 
identified using the immune antisera. A transmission electron 
micrograph (Fig 6A) demonstrated gold label present asym-
metrically on the RBC membrane, while control incubations 
with preimmune sera revealed no significant localization of the 
gold marker (Fig 6B). In other experiments, a plasma surface 
membrane marker, cationic ferritin [23], was noted to bind to 
the same side of the RBC membrane as the Sa, indicating that 
the venom frac t ion interacted exclusively with the outer leaflet 
of the plasma membrane (Fig 6C). 
DISCUSSION 
In this study, we have examined the adsorption of BR spider 
venom to cell membranes, an interaction which may initiate 
t he biologic events preceding the formation of the necrotic skin 
lesions. Many studies have used different venom fractions [5-
8) to examine t he complex biologic and biochemical properties 
of the BR venom. We have focused our studies on a purifted 
venom fraction which produces dermonecrosis containing pri-
marily a M, = 34,000 protein with sphingomyelinase D activity 
similar to that previously reported [7,24]. Using biologic assays, 
electroblot transfer of venom components, and specific anti-
body, we have demonstrated the high affinity of aM,= 34,000 
venom protein for biologic membranes and have inhibited the 
dermonecrotic activity of crude venom, purified S3, and S:r 
membrane complexes with specific antibody. 
In clinical lesions, whether or not the dermonecrotic activity 
is due to the combination of multiple venom factors acting on 
~he membrane is not clear. However, the s~ fraction does engage 
m high-affinity interaction with the cell membrane while main-
taining its ability to induce skin necrosis following injection of 
the complex. The mechanism of the 8:,-membrane interaction 
remains speculative since these studies did not address the 
~la~si~ princ~ples of binding, e.g., saturability, reversibility, or 
mhtb1t10n with unlabeled ligand. There is a possibility that a 
~lass. II membrane receptor [25) exists for the 8 :J fraction. There 
IS e.vidence that divalent cations (Mg++) are required for acti-
v~tw.n o~ the sphingomyelinase D activity [26] . Asymmetric 
d1stnbutwn of venom on the plasma surface of the cell mem-
brane noted by ultrastructural examination in our experiments 
suggests that the receptor may be sphingomyelin, which is 
present m large concentrations on the outer plasma leaflet of 
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FIG 6. Demonstration of the S3 
bound to membrane by electron micros-
copy. A, Human RBC membranes incu-
bated with Sa fraction, hyperimmune 
sera and labeled with protein A- gold. 
Note the asymmetric distribution of gold 
particles. Bar= 0.25 JLm. B, Human RBC 
membranes incubated with Sa fraction , 
nonimmune sera and labeled with pro-
tein A- gold. Bar = 0.25 JLm. C, Human 
RBC membranes incubated with S3 frac -
tion , hyperimmune sera, cationic ferri-
tin, and protein A- gold. Both electron-
dense markers are located on the same 
side of the membranes. Bar = 100 nm. 
the human RBC membrane. Recent studies by Tomita et al 
[27] support this mechanism since sphingomyelinase purified 
from Bacillus cereus binds to the RBC membrane. An alterna-
tive explanation to a specific receptor hypothesis is that the 8 3 
fraction has a highly amphophilic secondary structure similar 
to melittin [28], which allows adsorption to the cell me~brane. 
This w~uld allo~ the sphingomyelinase D enzyme to hydrolyze 
the sphmgomyelm substrate present on the exterior surface of 
the membra~e. Certainly, experiments in our laboratory with 
the S3 fractiOn have been hampered by its adherence to all 
surfaces (unpublished data). 
Although it is unclear how the S3 fraction interacts with the 
membrane, the generation of the dermonecrotic lesion may 
resu~t from me'?brane damage which activates inflammatory 
mediators. ObviOusly, the generation of phospholipid-derived 
inflammatory substances [29], such as prostaglandins, throm-
b~xanes , hydroxytetracosanic acids (HETEs), and leuko-
tnenes, contributes to the inflammatory reaction which is 
amplified by complement [ll] and/or C-reactive protein [12] 
to produc~ the necrotic skin lesion. These inflammatory factors, 
coupled. with v~scular thrombosis [1] from platelet aggregation, 
lead to Ischemia and further tissue injury. 
. S.in.ce crude venom, 83 or 8 r membrane complexes can be 
mh1b1ted by antibody, it may have therapeutic usefulness and 
clinical studies are under way. Clearly, the prevention of' skin 
necro~is and/or delayed wound healing is the goal of t herapy. 
~f antibody can neutralize the BR venom in the clinical wound, 
It would be a useful adjunct to dapsone [30], steroids [2], or 
other modes of treatment. 
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